covid-19 vaccine for kids | covaxin gets approval for phase 2-3 clinical trials for 2-18 age group
Published 3 years ago • 4.2K plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
17:53
covid vaccine for kids: covaxin approved for children in 2-18 age group | covid 360
-
9:40
covid vaccine: covaxin approved for kids aged 2-18 years | breaking news
-
0:45
coronavirus vaccine news | covaxin's phase 2 and 3 trials for kids soon, expert panel gives nod
-
2:16
bharat biotech’s 'covaxin' gets dcgi nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
-
2:00
covaxin clinical trials for children (2 – 18 years) approved by dcgi
-
12:01
covid vaccine news: covaxin for children soon; when to use remdesivir?; & more | india today
-
4:01
covaxin trials for kids in india: here's all you need to know | india today
-
3:58
major breakthrough in covid-19 treatment, bharat biotech's covaxin vaccine gets nod for human trials
-
11:55
covaxin gets emergency use approval for kids aged 2-18 years | breaking news
-
3:37
parents' reaction as covaxin gets approval for kids aged 2-18 years | reporter diary
-
3:52
bharat biotech's covaxin recommended by expert panel for phase 2/3 trials on children
-
2:27
expert panel approves covaxin phase 2& 3 trials for children between 2-18 years
-
2:41
what parents' say over covaxin gets approval for kids aged 2-18 years | reporter diary
-
4:05
covaxin gets nod for phase 2/3 trials on 2-18 year-olds: why it is significant
-
13:44
covaxin approved for kids in 2-18 age groups, dr rahul pandit speaks to india today
-
3:04
coronavirus vaccine | covaxin recommended for next phase of trials for 2-18 age group: report
-
12:08
relief for parents as covaxin gets emergency use approval for kids aged 2-18 years | 6 pm prime
-
8:34
covaxin approved for trial on children above 12 years, covishield above age 18| covid vaccine news
-
0:50
covaxin for kids: bharat biotech completes phase 2/3 trials, to submit data to dcgi next week
-
2:18
bharat biotech’s 'covaxin' gets sec nod for phase 2-3 clinical trials on 2 to 18 year-olds
-
1:35
covaxin gets emergency use approval for children aged 2-18 years
-
4:00
covaxin for kids: sec approves bharat biotech's covid vaccine for children from 2 to 18 yrs